Mechanisms of coronary vasoconstriction induced by Na arachidonate in experimentally diabetic dogs.
D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D001158:Arteries; D003331:Coronary Vessels / Q000503:physiopathology*; D016861:Cyclooxygenase Inhibitors; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000037:antagonists & inhibitors; D016859:Lipoxygenase Inhibitors; D010180:Pancreatectomy; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors; D014661:Vasoconstriction / Q000187:drug effects*
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D016859:Lipoxygenase Inhibitors; D013928:Thromboxane A2; D011464:Epoprostenol